---
title: "Sastasundar Ventures Ltd (SASTASUNDR) — Share Price, Financials & Analysis"
symbol: "SASTASUNDR"
company: "Sastasundar Ventures Ltd"
canonical: "https://tapetide.com/stocks/SASTASUNDR"
isin: "INE019J01013"
nse_symbol: "HEALTHX"
bse_code: "533259"
sector: "Healthcare Services"
industry: "Healthcare Service Provider"
market_cap_cr: 941.59
generated_at: "2026-09-13T19:15:40.642Z"
---

# Sastasundar Ventures Ltd (SASTASUNDR)

Canonical page: https://tapetide.com/stocks/SASTASUNDR

## Company

- **NSE Symbol:** HEALTHX
- **BSE Code:** 533259
- **ISIN:** INE019J01013
- **Sector:** Healthcare Services
- **Industry:** Healthcare Service Provider
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2010-10-05
- **CEO:** Mr. Banwari Lal Mittal
- **Employees:** 1657
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** sastasundarventures.com

## About

Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services[1]

## Latest Price

- **Price:** ₹308.15
- **Change:** +2.8 (+0.92%)
- **Open:** ₹301
- **Day High:** ₹310
- **Day Low:** ₹295.05
- **Previous Close:** ₹305.35
- **Volume:** 3397
- **As Of:** 2026-09-11T09:59:46+00:00

## Key Fundamentals

Observed at 2026-09-11T04:47:54.173713Z.

- **Market Cap:** ₹941.59 Cr
- **Classification:** Microcap
- **P/E (reported):** -37.5
- **P/E (TTM):** 37.63
- **EPS (TTM):** ₹8.19
- **EPS (reported):** ₹11.87
- **Book Value:** ₹201.47
- **Price to Book:** 1.52
- **Dividend Yield:** 0%
- **ROE:** -15.45%
- **ROCE:** -23.4%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹1319.27 Cr
- **Net Income:** ₹-3.17 Cr
- **EBITDA:** ₹-53.24 Cr
- **52-Week High:** ₹363
- **52-Week Low:** ₹252.5
- **RSI (14):** 53.53

## Tapetide Score

- **Score:** 35 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 6 (of 4473 scored stocks)
- **Confidence:** 95%
- **Data coverage:** 90%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 34.7 | 9% |
| growth | 32.68 | 9% |
| momentum | 38.84 | 12% |
| ownership | 42.13 | 24% |
| quality | 17.19 | 22% |
| valuation | 45.23 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has delivered good profit growth of 23.3% CAGR over last 5 years
- Company's median sales growth is 39.5% of last 10 years
- Company's working capital requirements have reduced from 66.1 days to 47.0 days

### Weaknesses

- Company has a low return on equity of -1.12% over last 3 years.
- Earnings include an other income of Rs.66.2 Cr.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -148.27% | 84.54% | 43.26% |
| ebitda margin growth | 136.29% | — | -184.28% | -32.99% |
| net income growth | 115.38% | -97.63% | 43% | 23% |
| revenue growth | 18.63% | 12.68% | -14% | 24% |
| roce | -117.85% | 750.91% | 111.19% | 9.61% |
| roe | -115.34% | — | -8.29% | 107.38% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 313.15 | 336.05 | 358.49 | 374.5 | 306.67 | 270.29 | 273.53 | 281.29 | 285.84 | 298.43 | 301.32 | 345.74 |
| Expenses | 324.32 | 326.79 | 355.12 | 371.07 | 317.32 | 272.69 | 278.25 | 304.99 | 311.04 | 292.37 | 323.93 | 356.1 |
| Operating Profit | -11.17 | 9.26 | 3.37 | 3.43 | -10.65 | -2.4 | -4.72 | -23.7 | -25.2 | 6.06 | -22.61 | -10.36 |
| OPM % | -3.57 | 2.76 | 0.94 | 0.92 | -3.47 | -0.89 | -1.73 | -8.43 | -8.82 | 2.03 | -7.5 | -3 |
| Other Income | 8.63 | 12.11 | 9.71 | 20.13 | 18.46 | 28.75 | -167.39 | -14.06 | 21.91 | 25.38 | 5.34 | 13.62 |
| Interest | 0.26 | 0.25 | 0.24 | 0.24 | 0.27 | 0.1 | 0.06 | 0.05 | 0.01 | 0.09 | 0.04 | 0.17 |
| Depreciation | 2.8 | 2.09 | 2.2 | 2.31 | 2.53 | 1.61 | 1.45 | 1.43 | 1.34 | 1.17 | 1.33 | 2.17 |
| Profit before tax | -5.6 | 19.03 | 10.64 | 21.01 | 5.01 | 24.64 | -173.62 | -39.24 | -4.64 | 30.18 | -18.64 | 0.92 |
| Tax % | 287.5 | -28.85 | -23.03 | 3.86 | -583.03 | -102.8 | -13.17 | 1.99 | -478.45 | 11.9 | -17.17 | 59.78 |
| Net Profit | -48 | -0.28 | -12.2 | -3.23 | 21.58 | 40.96 | -154.78 | -37.8 | 17.57 | 26.59 | -15.44 | 0.37 |
| EPS in Rs | -10.75 | 0.41 | -2.55 | -0.24 | 5.17 | 9.79 | -34.39 | -8.47 | 4.3 | 7.52 | -3.99 | 0.36 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 135 | 162 | 222 | 388 | 551 | 1798 | 1060 | 1432 | 1159 | 1231 |
| Expenses | 155 | 175 | 255 | 440 | 561 | 684 | 1168 | 1456 | 1177 | 1283 |
| Operating Profit | -20 | -13 | -33 | -52 | -10 | 1114 | -107 | -24 | -19 | -52 |
| OPM % | -15 | -8 | -15 | -13 | -2 | 62 | -10 | -2 | -2 | -4 |
| Other Income | 2 | 7 | 0 | 1 | 1 | 3 | -5 | 4 | -179 | 66 |
| Interest | 3 | 1 | 3 | 1 | 3 | 3 | 2 | 1 | 0 | 0 |
| Depreciation | 7 | 6 | 6 | 5 | 4 | 4 | 8 | 9 | 6 | 6 |
| Profit before tax | -28 | -12 | -42 | -58 | -16 | 1109 | -122 | -30 | -204 | 8 |
| Tax % | 2 | 19 | 3 | -9 | 4 | 22 | -19 | -119 | -34 | — |
| Net Profit | -29 | -15 | -43 | -52 | -17 | 865 | -99 | 6 | -134 | 29 |
| EPS in Rs | -9 | -3.73 | -11.81 | -12.19 | -3.27 | 197.05 | -22.7 | 2.79 | -28.66 | 8.19 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 163 | 144 | 111 | 178 | 168 | 795 | 722 | 731 | 638 | 650 |
| Borrowings | 21 | 12 | 2 | 8 | 12 | 2 | 9 | 4 | 1 | 5 |
| Other Liabilities | 35 | 48 | 86 | 98 | 80 | 449 | 441 | 383 | 300 | 321 |
| Total Liabilities | 251 | 235 | 230 | 316 | 293 | 1278 | 1204 | 1149 | 970 | 1008 |
| Fixed Assets | 125 | 117 | 116 | 114 | 110 | 93 | 107 | 110 | 102 | 117 |
| CWIP | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 10 | 1 |
| Investments | 17 | 46 | 36 | 56 | 43 | 666 | 513 | 676 | 575 | 633 |
| Other Assets | 110 | 71 | 77 | 146 | 139 | 518 | 583 | 363 | 283 | 257 |
| Total Assets | 251 | 235 | 230 | 316 | 293 | 1278 | 1204 | 1149 | 970 | 1008 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -12 | -2 | -49 | -30 | -69 | -31 | -207 | -112 | 36 | -17 |
| Cash from Investing Activity | -1 | 4 | 15 | -2 | -22 | 21 | 220 | 133 | -34 | -1 |
| Cash from Financing Activity | 13 | 5 | 33 | 26 | 103 | 4 | -11 | -2 | -2 | 0 |
| Net Cash Flow | 0 | 7 | -2 | -6 | 11 | -5 | 1 | 19 | 0 | -19 |
| Free Cash Flow | -18 | 0 | -55 | -33 | -71 | -31 | -212 | -128 | 22 | -27 |
| CFO/OP | 43 | 17 | 377 | 89 | 133 | 288 | -8 | 104 | -172 | 68 |

### Ratios

| Item | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 34 | 52 | 9 | 13 | 14 | 9 | 4 | 12 | 9 | 3 |
| Inventory Days | 91 | 80 | 73 | 59 | 77 | 57 | 71 | 69 | 34 | 40 |
| Days Payable | 38 | 69 | 24 | 26 | 50 | 29 | 21 | 22 | 13 | 21 |
| Cash Conversion Cycle | 87 | 62 | 58 | 46 | 41 | 38 | 55 | 59 | 31 | 22 |
| Working Capital Days | 182 | 49 | 61 | 61 | 54 | 44 | 46 | 93 | 58 | 47 |
| ROCE % | -14 | -12 | -8 | -19 | -25 | -6 | -7 | -11 | -3 | -1 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 73.92% | 73.92% | 73.92% | 73.92% | 73.92% | 73.94% | 74.11% | 74.24% | 74.24% | 74.69% | 74.84% | 74.07% |
| FIIs | 0.32% | 0.49% | 0.56% | 0.61% | 0.99% | 1.71% | 1.6% | 1.88% | 2.04% | 2.25% | 2.17% | 2.29% |
| DIIs | 0.17% | 0.86% | 0.96% | 1.35% | 1.98% | 1.85% | 2.06% | 2.09% | 2.07% | 2.07% | 2.6% | 2.6% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 15.64% | 16.52% | 16.06% | 15.05% | 14.47% | 14.09% | 13.7% | 13.35% | 12.84% | 12.72% | 12.25% | 11.95% |
| Others | 9.95% | 8.2% | 8.51% | 9.07% | 8.63% | 8.41% | 8.52% | 8.44% | 8.81% | 8.27% | 8.15% | 9.09% |
| No. of Shareholders | 14633 | 14053 | 14544 | 14493 | 15360 | 14093 | 13693 | 13452 | 13012 | 12287 | 11845 | 11502 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 5 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 299.84 | Buy |
| EMA (10) | 301.33 | Buy |
| SMA (20) | 299.1 | Buy |
| EMA (20) | 300.93 | Buy |
| SMA (50) | 307.89 | Buy |
| EMA (50) | 303.04 | Buy |
| SMA (100) | 302.13 | Buy |
| EMA (100) | 301.67 | Buy |
| SMA (200) | 298.22 | Buy |
| EMA (200) | 296.76 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 55.59 | Neutral |
| MACD (12,26,9) | -0.53 | Buy |
| Stochastic (14,3,3) | 67.88 | Neutral |
| ADX (14) | 22.96 | Neutral |
| Williams %R (14) | -15.51 | Sell |
| ATR (14) | 13.69 | High Volatility |
| ROC (12) | 3.34 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 53.51 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c71cd545-c185-4468-bf75-f81251ae7f5f.pdf) |
| 2026-09-04 | [Notice Of The 37Th Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0c17785-30f1-4d5f-9903-13e88817f75a.pdf) |
| 2026-09-04 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=805d3c77-f482-47c9-947c-a745a671c4c9.pdf) |
| 2026-09-04 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d355e249-58af-4758-a06c-bc077bc6a6de.pdf) |
| 2026-09-04 | [Dispatch Of Letter To Shareholders Whose E-Mail Addresses Are Not Registered With The Company Or RTA Or Depository Participants](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84be14e8-3dd7-4896-b2cf-0568469af034.pdf) |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fa65cb8-38ca-4f67-a4c4-da06bf6ce772.pdf) |
| 2026-08-31 | [Intimation Regarding The 37Th Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7e63b18-906e-41f0-ac58-9b1352f6da2c.pdf) |
| 2026-08-25 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52f7aebf-1227-4ac6-a160-cb45949f8b7f.pdf) |
| 2026-08-08 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7074275f-df93-4d3c-819a-a6029e84bfa6.pdf) |
| 2026-08-07 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 7Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d48a3ca-94ed-45ba-a819-9088155822ec.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e272eecf-232c-4890-9c00-f3ccf8bdb7ae.pdf) |
| 2026-06-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=207204e0-ce2a-47c4-a34e-37eec4f87736.pdf) |
| 2026-02-16 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd3ff48d-d13b-4966-ba17-a2a443622da3.pdf) |
| 2025-11-24 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8af28204-77c6-4a3d-8790-3a1fa7344d38.pdf) |
| 2025-06-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=440d3301-6900-427a-a46a-80ef6a609290.pdf) |
| 2024-11-25 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=982ad4db-ceb7-4606-9c7e-f74d0efb639f.pdf) |
| 2024-02-08 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e71a6e85-827a-4e2a-addb-da074946fd47.pdf) |
| 2023-11-23 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ea1595c-128c-4222-9760-0abcd1b9db85.pdf) |
| 2023-08-24 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03eff4aa-aec3-418e-8a38-a8fb7a53e6ee.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df7a7d18-1c68-4d9d-9eaa-e2839cd7c243.pdf) |
| 2026-06-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e1581c7-2f65-49fe-9f9a-5e0cc3c251de.pdf) |
| 2026-02-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dffa12c-a735-4ab7-9611-be3c91a2b12a.pdf) |
| 2025-11-17 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a5d791b-66ed-4628-8f66-6d9abc34aa98.pdf) |
| 2025-06-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=998760cd-1ce4-435e-8e89-94053100b657.pdf) |
| 2024-11-18 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04c46a85-6bf3-4649-8e37-589854e6af62.pdf) |
| 2024-02-02 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1217a218-0562-4344-b879-5a6d0e426b04.pdf) |
| 2023-11-16 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8be62cb-a71e-4632-9fb0-315bb817ab86.pdf) |
| 2023-08-17 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=773c6f0d-acbe-4dc4-ae08-133f79583889.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-07 | [Results - Unaudited Financial Results For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d19ef00e-026a-4f85-a0e4-3ace88e52e57.pdf) |
| 2026-05-30 | [Results - Financial Results For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7888f215-5b3a-4a1c-ac0d-f6bae66c06a6.pdf) |
| 2026-02-06 | [Results - Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=799764b1-2bc2-4e4f-9d26-0c64e8ffdaa4.pdf) |
| 2025-11-13 | [Results - Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5e6120e-32d2-4b63-afc2-a26a94de72ad.pdf) |
| 2025-08-12 | [Results - Unaudited Financial Results Standalone And Consolidated For The Quarter Ended 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2ae3bb4-d155-4b7c-9159-bc24db6048a3.pdf) |
| 2025-05-30 | [Results - Audited Financial Results As On 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2236ea3-6e2f-4790-b5e2-ca2713fe4f69.pdf) |
| 2025-02-14 | [Results - Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=312dfec9-a0e2-47d5-8734-ffd50519052e.pdf) |
| 2024-11-14 | [Results - Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac503b38-0242-4576-abfa-0c18887916ec.pdf) |
| 2024-07-29 | [Results - Unaudited Financial Results For The Quarter Ended June 30, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bdd1c21-ab4b-48d8-8269-2a8d18086e5f.pdf) |
| 2024-05-30 | [Results - Financial Results For The Quarter And Financial Year Ended 31St March 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b247b040-f016-49c1-886e-e9dfdcff79db.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f48506bb-fff8-4084-8b6c-17c8fa93cea0.pdf) |
| 2026-06-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fb4420d-05df-4d16-ac5c-8285482e5d20.pdf) |
| 2026-06-01 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6941cf6a-ff7f-4f3d-94fe-22890c6154e3.pdf) |
| 2026-02-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acde87eb-e98b-4ea3-b4d7-32470b948f8a.pdf) |
| 2026-02-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2478904-59c6-459b-aec4-bcc310938568.pdf) |
| 2025-11-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ce373e6-ad1c-4b5d-97c7-754aa8ed710b.pdf) |
| 2025-08-16 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bed173d-d3d6-486e-8cf9-e48e476a31cf.pdf) |
| 2025-06-02 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=543ab431-2924-4075-9c82-c82659bb0922.pdf) |
| 2025-02-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a23926c-29cc-4c70-be8e-27840e711ab7.pdf) |
| 2024-11-16 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c879d941-87ac-43c7-a4fd-e3894b164028.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2022 | [Concall - Sep 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c4ea8984-37b8-4d91-a69c-0ee9286cfc30.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f562d3d5-d2c0-42f8-a4b3-9d8913f197b0.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8af28204-77c6-4a3d-8790-3a1fa7344d38.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/982ad4db-ceb7-4606-9c7e-f74d0efb639f.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6ea1595c-128c-4222-9760-0abcd1b9db85.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/541c3044-e927-405e-9e2f-1c77ac738bc6.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4405952f-aa4e-4bcd-8e3d-de7b042217f2.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/797d26a0-aa4a-4158-b932-27212ab288e3.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a45830a2-cd96-4c30-a94e-9f72d95daadd.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a45830a2-cd96-4c30-a94e-9f72d95daadd.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 6 Apr - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Reg, 2018 for the quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Reg, 2018 for the quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0e410c80-ac1a-4d02-a128-c80eb113c4d2.pdf) |
| 5 Mar - Of Schedule of Analysts/ Institutional Investors Meeting under the SEBI (LODR) Reg, 2015 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 5 Mar - Of Schedule of Analysts/ Institutional Investors Meeting under the SEBI (LODR) Reg, 2015](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f692bb93-6b08-4325-b595-82ea27f77b5a.pdf) |
| 27 Mar - Promoter Banwari Lal Mittal bought 5,000 shares on 24-Mar-2026; holding 10,786,355 (33.9081%), value Rs.14,02,882.05. | [Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg, 2015 27 Mar - Promoter Banwari Lal Mittal bought 5,000 shares on 24-Mar-2026; holding 10,786,355 (33.9081%), value Rs.14,02,882.05.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cae05db8-abe5-4cd5-b78f-a4ec0528ed28.pdf) |
| 27 Feb - Tripartite Agreement: Envision acquires Mitsubishi's SHBL stake; scheme to merge SHBL into HealthX; Envision may get board seat. | [Disclosure under Regulation 30A of LODR 27 Feb - Tripartite Agreement: Envision acquires Mitsubishi's SHBL stake; scheme to merge SHBL into HealthX; Envision may get board seat.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/535eb430-032e-45b2-90d5-df70d84c1940.pdf) |
| 27 Feb - Envision to acquire Mitsubishi's SHBL shares (SPA 25 Feb 2026); tripartite agreement for merger/share-swap; board appointment rights. | [Disclosure Under Reg 30(9) Of SEBI (LODR) - Intimation By Sastasundar Healthbuddy Limited, Material Subsidiary Regarding Outcome Of Its Board Meeting 27 Feb - Envision to acquire Mitsubishi's SHBL shares (SPA 25 Feb 2026); tripartite agreement for merger/share-swap; board appointment rights.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1991fb90-9e30-4e10-9db7-33553e9cc02f.pdf) |
| 27 Feb - Board approved tripartite agreement: Envision acquires Mitsubishi's SHBL stake (SPA 25-Feb-2026); merger or share-swap into HealthX. | [Board Meeting Outcome for Disclosure Under Reg 30 Of SEBI (LODR) - Outcome Of Meeting Of The Board 27 Feb - Board approved tripartite agreement: Envision acquires Mitsubishi's SHBL stake (SPA 25-Feb-2026); merger or share-swap into HealthX.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b3273b82-3419-49ae-a3a8-32b53be640ef.pdf) |
| 26 Feb - SHBL approved in-principle merger into Health X Platform; contingent on Mitsubishi sale to Envision (SPA dated 25.02.2026). | [Disclosure Under Reg 30 (LODR) - Intimation By Sastasundar Healthbuddy Limited, Material Subsidiary Regarding Outcome Of Its Board Meeting 26 Feb - SHBL approved in-principle merger into Health X Platform; contingent on Mitsubishi sale to Envision (SPA dated 25.02.2026).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/56bbd16a-ef26-4b9b-a0c2-58625b2c2e28.pdf) |
| 25 Apr - BSE and NSE approved name change to Health X Platform Limited, effective April 30, 2026. | [Approval From Stock Exchange For Change In Name And Symbol 25 Apr - BSE and NSE approved name change to Health X Platform Limited, effective April 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/80f42f31-d07c-4104-b70e-26ab54ac8ecf.pdf) |
| 24 Apr - Revised CA certificate filed to support name change to Health X Platform Limited. | [Update On Application To Stock Exchanges For Change In Name Of The Company 24 Apr - Revised CA certificate filed to support name change to Health X Platform Limited.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/89931425-2265-4e92-8201-2edd598e2bed.pdf) |
| 23 Mar - Promoter Banwari Lal Mittal bought 5,132 shares (Rs14,44,315.44) on 21-03-2026; holdings 1,07,81,355 (33.8924%). | [Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg, 2015 23 Mar - Promoter Banwari Lal Mittal bought 5,132 shares (Rs14,44,315.44) on 21-03-2026; holdings 1,07,81,355 (33.8924%).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/086fb02b-0c90-47d0-9477-6ba9aeb7dd98.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/07434f13-418d-4db6-bb03-f2d2a6dcf515.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/79a73ef8-b5b2-4d7e-b734-86bc22d4540a.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fe44cfe6-7cb3-45df-ab98-d816f120da72.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/533259/76611533259.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/533259/71176533259.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/533259/5332590320.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/533259/5332590319.pdf) |
| from bse | [Financial Year 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/533259/5332590318.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:15:40.642Z.